Literature DB >> 9421067

The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix.

M W Jones1, S Kounelis, H Papadaki, A Bakker, P A Swalsky, S D Finkelstein.   

Abstract

Five cases of adenoid basal carcinoma (ABC) of the uterine cervix were examined for the presence of p53 tumor suppressor gene, K-ras-2 oncogene, and human papillomavirus (HPV). A topographic genotyping approach was used to search for point mutations in K-ras-2 (exon 1 and 2) and p53 (exons 5 to 8) in archival formalin-fixed tissue blocks. Minute target sites were selected from polymerase chain reaction (PCR) amplified and directly sequenced tissue sections. Tissue sections were additionally subjected to immunohistochemical staining for p53 and WAF-1 protein. Because wild type p53 induces WAF-1 gene expression, immunohistochemical staining for WAF-1 protein using monoclonal antibodies may serve as an indirect means to test for p53 mutational damage. Mutational genotype was compared to histopathologic features and immunohistochemical staining. To study the role of HPV, L1 region consensus primers were used to amplify topographic samples, followed by HPV genotyping by direct sequencing and comparison to known viral strains. ABC was found to contain HPV in all cases, proven by genotyping to be HPV type 16 in each case. The virus showed no evidence of genomic variation from prototype HPV type 16 in the L1 segment examined. No K-ras-2 point mutations were identified. p53 immunopositivity was present in all tumors, being weak and focal in 4 and strong and diffuse in 1. WAF-1 immunostaining was positive in two tumors showing weak focal p53 immunopositivity. The single strong and diffuse p53 immunopositive tumor was negative for WAF-1 and was shown to contain a missense p53 point mutation (exon 7-codon 248 tryptophan). In conclusion, ABC is characterized by the presence of HPV type 16. K-ras-2 point mutation appears to play no role in the development of this tumor. p53 gene alterations are common including wild type hyperexpression (weak focal p53 immunopositivity, WAF-1 positivity, no mutational change) and p53 point mutational damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9421067     DOI: 10.1097/00004347-199710000-00002

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  5 in total

1.  Cervical adenoid basal carcinoma associated with invasive squamous cell carcinoma: a report of rare co-existence and review of literature.

Authors:  Boonlert Viriyapak; Sung Taek Park; Ah Won Lee; Jong Sup Park; Chung Won Lee; Min Jong Song; Soo Young Hur
Journal:  World J Surg Oncol       Date:  2011-10-18       Impact factor: 2.754

2.  Adenoid basal carcinoma of the cervix in a 20-year-old female: a case report.

Authors:  William David DePond; Victor Santos Flauta; Daniel Christian Lingamfelter; David Mark Schnee; Kristyn Poncy Menendez
Journal:  Diagn Pathol       Date:  2006-08-16       Impact factor: 2.644

3.  Adenoid basal carcinoma arising in the cervical polyp: an immunohistochemical study of stromal cells.

Authors:  Naoto Kuroda; Kohki Hirano; Masahiko Ohara; Takashi Hirouchi; Keiko Mizuno; Ayumi Kubo; Hideaki Enzan
Journal:  Med Mol Morphol       Date:  2007-06-18       Impact factor: 2.309

4.  Cervical adenoid Basal carcinoma: a case report.

Authors:  Asuman Argon; Alper Sener; Osman Zekioğlu; Coşan Terek; Necmettin Ozdemir
Journal:  Balkan Med J       Date:  2012-12-01       Impact factor: 2.021

5.  Adenoid basal lesions of the uterine cervix: evolving terminology and clinicopathological concepts.

Authors:  Michael J Russell; Oluwole Fadare
Journal:  Diagn Pathol       Date:  2006-08-15       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.